HomeENLV • NASDAQ
add
Enlivex Therapeutics Ltd
Previous close
$1.33
Day range
$1.28 - $1.33
Year range
$1.15 - $4.59
Market cap
27.27M USD
Avg Volume
78.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.95M | -41.77% |
Net income | -4.14M | 42.64% |
Net profit margin | — | — |
Earnings per share | -0.22 | 43.59% |
EBITDA | -3.76M | 42.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.44M | -34.86% |
Total assets | 31.05M | -48.27% |
Total liabilities | 4.20M | -55.59% |
Total equity | 26.85M | — |
Shares outstanding | 18.81M | — |
Price to book | 0.93 | — |
Return on assets | -29.10% | — |
Return on capital | -33.53% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -4.14M | 42.64% |
Cash from operations | -4.51M | 22.03% |
Cash from investing | 5.10M | 116.26% |
Cash from financing | 524.00K | 64.78% |
Net change in cash | 1.11M | 103.02% |
Free cash flow | -2.89M | 32.27% |
About
Founded
Jan 22, 2012
Website
Employees
49